Compounded Tirzepatide Recall Exposes Sterility Gaps in GLP-1 Supply Chain
Apothecary Pharma recalled compounded tirzepatide for sterility concerns, classified Class II by the FDA, as inspectors documented mold at a Chinese ingredient factory.
Apothecary Pharma recalled compounded tirzepatide for sterility concerns, classified Class II by the FDA, as inspectors documented mold at a Chinese ingredient factory.